Blog
RSS FeedPosted by Michael Wonder on 19 May 2022
Budget 2022: critically ill patients 'bitterly disappointed' by PHARMAC funding
19 May 2022 - Critically ill patients say they're "bitterly disappointed" by today's PHARMAC Budget announcement and were left looking ...
Posted by Michael Wonder on 19 May 2022
Budget 2022: PHARMAC boost leaves patients cold: 'it won't be enough'
19 May 2022 - PHARMAC has had its biggest ever funding boost, but some New Zealanders fear it still won’t ...
Posted by Michael Wonder on 19 May 2022
Multiple funding proposals being considered by PHARMAC
19 May 2022 - PHARMAC has issued three consultations today on proposals to fund medicines for conditions including cancer, multiple sclerosis, ...
Posted by Michael Wonder on 19 May 2022
PHARMAC will use biggest budget increase ever to fund more medicines for more New Zealanders
19 May 2022 - PHARMAC welcomes the $191 million increase to its pharmaceutical budget over the next two years. ...
Posted by Michael Wonder on 18 May 2022
Budget 2022: two year old girl and mum travel to Wellington in hopes of getting funding for devastating spinal illness
19 May 2022 - Dozens of people are travelling to Wellington for the Budget to highlight concerns about sick children ...
Posted by Michael Wonder on 18 May 2022
Cancer patient stares down the cost of buying time
18 May 2022 - It’s heartbreaking, frustrating, and it blows her mind. ...
Posted by Michael Wonder on 17 May 2022
The drugs that give her life cost more than half the family's income
18 May 2022 - For Vickie Hudson-Craig, this year’s Budget could mean the difference between life and death. ...
Posted by Michael Wonder on 16 May 2022
PHARMAC widens access to medicine for RSV
16 May 2022 - PHARMAC has announced today that it will be funding the preventative treatment, palivizumab, for the next two ...
Posted by Michael Wonder on 15 May 2022
PHARMAC publishes agenda for May 2022 PTAC meeting
12 May 2022 - Yet another PTAC meeting with very few applications for new medicines/medicines still under patent protection. ...
Posted by Michael Wonder on 10 May 2022
Calls for Health Minister to release final report from PHARMAC review
11 May 2022 - Health Minister Andrew Little is facing calls to release the final report from a review of ...
Posted by Michael Wonder on 04 May 2022
People with multiple sclerosis unable to access 'life-changing' treatment in NZ
5 May 2022 - New Zealanders with multiple sclerosis say their only hope of slowing the disease is not available ...
Posted by Michael Wonder on 02 May 2022
Mum and son hold their breath for cystic fibrosis drug Trikafta ahead of Budget
29 April 2022 - Hamish Mountfort is a smart, well-spoken and confident 22-year-old who’s dying, literally, to dedicate his life ...
Posted by Michael Wonder on 01 May 2022
New Zealand Pharmaceutical Schedule - 1 May 2022
1 May 2022 - The May 2022 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 28 Apr 2022
Cancer agency report duplicates PHARMAC role
28 April 2022 - The Cancer Control Agency’s analysis of the gap between Australia and New Zealand in funding 18 selected ...
Posted by Michael Wonder on 28 Apr 2022
Access criteria for antiviral treatments widened as molnupiravir arrives in New Zealand
28 April 2022 - PHARMAC is widening access to the antivirals to treat people with early COVID-19, after receiving feedback from ...